FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

39987211000001107: Episenta 300mg modified-release capsules (Desitin Pharma Ltd) 30 capsule (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 24-Nov 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2084791000001115 Episenta 300mg modified-release capsules (Desitin Pharma Ltd) 30 capsule en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2084801000001116 Episenta 300mg modified-release capsules (Desitin Pharma Ltd) 30 capsule (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Episenta 300mg modified-release capsules (Desitin Pharma Ltd) 30 capsule Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Episenta 300mg modified-release capsules (Desitin Pharma Ltd) 30 capsule Has AMP Episenta 300mg modified-release capsules (Beacon Pharmaceuticals Ltd) true Inferred relationship Existential restriction modifier
Episenta 300mg modified-release capsules (Desitin Pharma Ltd) 30 capsule Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Episenta 300mg modified-release capsules (Desitin Pharma Ltd) 30 capsule Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Episenta 300mg modified-release capsules (Desitin Pharma Ltd) 30 capsule Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Episenta 300mg modified-release capsules (Desitin Pharma Ltd) 30 capsule Is a Sodium valproate 300mg modified-release capsules 30 capsule true Inferred relationship Existential restriction modifier
Episenta 300mg modified-release capsules (Desitin Pharma Ltd) 30 capsule Has excipient Sorbic acid false Inferred relationship Existential restriction modifier
Episenta 300mg modified-release capsules (Desitin Pharma Ltd) 30 capsule VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Episenta 300mg modified-release capsules (Desitin Pharma Ltd) 30 capsule Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Episenta 300mg modified-release capsules (Desitin Pharma Ltd) 30 capsule Has dispensed dose form Modified-release oral capsule true Inferred relationship Existential restriction modifier
Episenta 300mg modified-release capsules (Desitin Pharma Ltd) 30 capsule VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Episenta 300mg modified-release capsules (Desitin Pharma Ltd) 30 capsule Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Episenta 300mg modified-release capsules (Desitin Pharma Ltd) 30 capsule Has specific active ingredient Valproate sodium true Inferred relationship Existential restriction modifier
Episenta 300mg modified-release capsules (Desitin Pharma Ltd) 30 capsule Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start